Showing results (251-260 of 547) with videos related to
Sort By:
Pageof 55
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2011
(3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivoDong Joon Kim, Kanamata Reddy, Myoung Ok Kim, et al.Molecular Carcinogenesis|July 1, 2014
Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growthSung Keun Jung, Mee-Hyun Lee, Do Young Lim, et al.Journal of Microbiology and Biotechnology|September 7, 2023
Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical EvidenceJung Hyun Kang, Zigang Dong, Seung Ho ShinNature Structural & Molecular Biology|February 7, 2012
ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4Myoung Ok Kim, Sung-Hyun Kim, Yong-Yeon Cho, et al.Carcinogenesis|October 14, 2017
Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODCDong Joon Kim, Mee-Hyun Lee, KangDong Liu, et al.Cancer Cell International|January 7, 2021
Cancer-related circular RNA: diverse biological functionsDan Cheng, Jing Wang, Zigang Dong, et al.STAR Protocols|February 25, 2026
Protocol for KAT8 conditional knockout mice generation and its application in 4NQO-induced esophageal tumor modelDandan Zhang, Ming Jiang, Kangdong Liu, et al.Carcinogenesis|August 6, 2013
The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancerSung Keun Jung, Jong Eun Kim, Sung-Young Lee, et al.Journal of Cellular Biochemistry|January 21, 2017
ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell TransformationBong Seok Kang, Yoon Jin Hwang, Zigang DongMolecular Carcinogenesis|August 14, 2024
Precision therapy for cancer prevention by targeting carcinogenesisGuoguo Jin, Kangdong Liu, Zhiping Guo, et al.Pageof 55